WallStreetZenWallStreetZen

AnalystsJustin Smith
Justin Smith's Stock Forecasts

Analyst Ranking
Top 50%
#2270 out of 4563 analysts
Average Return
+4.64%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good

Justin Smith's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Abbvie IncABBV
+24.94%$118.88$148.53
2021-11-23 -
2022-11-08
Strong Buy

Justin Smith Analyst Color

Get additional color on Justin Smith's coverage of popular stocks

Justin Smith's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Merck & Co IncMRK
1Strong Sell$104.00-18.11%Downgrades
a month ago
Abbvie IncABBV
3HoldN/AN/ADowngrades
a year ago
Bristol Myers Squibb CoBMY
2Strong Buy$76.00N/AUpgrades
3 years ago
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.